Monday August 17, 2009

Q; Is menstrual bleeding a contraindication to thrombolytic therapy in Acute MI or Stroke?



Answer: No

There may be a clinically significant increase in the risk of moderate bleeding during menstruation. But lifesaving benefit of thrombolytic therapy for acute myocardial infarction should generally not be withheld because of active menstruation. Potential patients should be advised that they might require transfusion for increased menstrual flow.